301 related articles for article (PubMed ID: 26005917)
21. Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating
Wu L; Yang Y; Wang Z; Wu X; Su F; Li M; Jing X; Han C
Molecules; 2020 Mar; 25(5):. PubMed ID: 32150865
[TBL] [Abstract][Full Text] [Related]
22. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
24. The development of chalcones as promising anticancer agents.
Ducki S
IDrugs; 2007 Jan; 10(1):42-6. PubMed ID: 17187314
[TBL] [Abstract][Full Text] [Related]
25. Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.
Mateeva N; Eyunni SVK; Redda KK; Ononuju U; Hansberry TD; Aikens C; Nag A
Bioorg Med Chem Lett; 2017 Jun; 27(11):2350-2356. PubMed ID: 28442256
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the Fluorescence Properties of 4-Dialkylaminochalcones and Investigation of the Cytotoxic Mechanism of Chalcones.
Zhou B; Jiang P; Lu J; Xing C
Arch Pharm (Weinheim); 2016 Jul; 349(7):539-52. PubMed ID: 27214789
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
Kupcewicz B; Jarzęcki AA; Małecka M; Krajewska U; Rozalski M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4260-5. PubMed ID: 25091929
[TBL] [Abstract][Full Text] [Related]
28. Natural chalcones as dual inhibitors of HDACs and NF-κB.
Orlikova B; Schnekenburger M; Zloh M; Golais F; Diederich M; Tasdemir D
Oncol Rep; 2012 Sep; 28(3):797-805. PubMed ID: 22710558
[TBL] [Abstract][Full Text] [Related]
29. Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives.
Mahapatra DK; Bharti SK; Asati V
Curr Top Med Chem; 2017 Nov; 17(28):3146-3169. PubMed ID: 28914193
[TBL] [Abstract][Full Text] [Related]
30. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
Loa J; Chow P; Zhang K
Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
[TBL] [Abstract][Full Text] [Related]
31. Effects of a combretastatin A4 analogous chalcone and its Pt-complex on cancer cells: A comparative study of uptake, cell cycle and damage to cellular compartments.
Zoldakova M; Kornyei Z; Brown A; Biersack B; Madarász E; Schobert R
Biochem Pharmacol; 2010 Nov; 80(10):1487-96. PubMed ID: 20709029
[TBL] [Abstract][Full Text] [Related]
32. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
Varinska L; van Wijhe M; Belleri M; Mitola S; Perjesi P; Presta M; Koolwijk P; Ivanova L; Mojzis J
Eur J Pharmacol; 2012 Sep; 691(1-3):125-33. PubMed ID: 22721615
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antitumor activity of novel nitrogen mustard-linked chalcones.
Fang X; Yang B; Cheng Z; Yang M; Su N; Zhou L; Zhou J
Arch Pharm (Weinheim); 2013 Apr; 346(4):292-9. PubMed ID: 23519571
[TBL] [Abstract][Full Text] [Related]
34. Unambiguous Identification of β-Tubulin as the Direct Cellular Target Responsible for the Cytotoxicity of Chalcone by Photoaffinity Labeling.
Zhou B; Yu X; Zhuang C; Villalta P; Lin Y; Lu J; Xing C
ChemMedChem; 2016 Jul; 11(13):1436-45. PubMed ID: 27203512
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of glycosides containing triazene-chalcones.
Lei Q; Zhang S; Liu M; Li J; Zhang X; Long Y
Mol Divers; 2017 Nov; 21(4):957-966. PubMed ID: 28791568
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2009 Dec; 17(23):7909-14. PubMed ID: 19875299
[TBL] [Abstract][Full Text] [Related]
38. Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.
Zhou J; Geng G; Batist G; Wu JH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1183-6. PubMed ID: 19138519
[TBL] [Abstract][Full Text] [Related]
39. A Review on Mechanisms of Anti Tumor Activity of Chalcones.
Sharma R; Kumar R; Kodwani R; Kapoor S; Khare A; Bansal R; Khurana S; Singh S; Thomas J; Roy B; Phartyal R; Saluja S; Kumar S
Anticancer Agents Med Chem; 2015; 16(2):200-11. PubMed ID: 25980813
[TBL] [Abstract][Full Text] [Related]
40. Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids.
Roman BI; De Ryck T; Verhasselt S; Bracke ME; Stevens CV
Bioorg Med Chem Lett; 2015 Mar; 25(5):1021-5. PubMed ID: 25666820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
